Doxium 500
Doxium 500 is a medicine authorised by Swissmedic under authorisation number 39217. The authorisation holder is OM Pharma SA. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 15 December 1975 and the authorisation is valid without a time limit. ATC code C05BX01 places the medicine in the group Vasoprotectives.
| Authorisation number | 39217 |
|---|---|
| Name | Doxium 500 |
| Full name | Doxium 500, capsules |
| Authorisation holder | OM Pharma SA |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | C05BX01 |
| First authorisation | 15 December 1975 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Doxium 500, capsules | B | 15 December 1975 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 23 | 30 | Kapsel(n) | C05BX01 | 02.08.1. | B |
| 31 | 60 | Kapsel(n) | C05BX01 | 02.08.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Doxium 500 authorised in Switzerland?
Yes. Doxium 500 is authorised by Swissmedic under authorisation number 39217, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Doxium 500 have?
Doxium 500 is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Doxium 500?
The authorisation holder is OM Pharma SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.